|
Inside This Issue - Opinion
Ending a 40-year career in retailing that has been as impressive in its diversity as it has been stunning in its achievements, Andy Giancamilli has stepped down as chief executive officer of Mississauga, Ontario-based Katz Drug. As the Federal Trade Commission ponders the potential ramifications of a $29 billion merger between Express Scripts and Medco Health Solutions, it confronts a number of weighty issues.
|